Vonoprazan Fumarate

Home > API & Intermediate > Digestive System Drugs > Vonoprazan Fumarate Manufacturers > Vonoprazan Fumarate

Vonoprazan Fumarate

CAS NO.： 1260141-27-2

FOB Price： NEGOTIABLE Get Latest Price

Specification： 99%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 25KG/Fibre Drum

Product Detail

Properties

Product Name：5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine 2-butenedioate (Vonoprazan)

CAS:1260141-27-2

Purity：99.0%

Inside Code：TAK09

Structural formula:

Vonolazan fumarate (tak-438, vonoprazan fumarate) is a novel oral antacid launched by Takeda pharmaceutical in collaboration with Otsuka pharmaceutical.

Properties

Vonolazan is undoubtedly a gold withdrawing antigastric drug, however, there is also some dissatisfaction with this drug due to previous corporate R & D failures with the p-cab class of drugs and intense competition for PPIs on the market. Even then, domestic firms still took the first time to declare vonolazan.

CAS No.

1260141-27-2

Formula

C21H20FN3O6S

Molecular Mass

461.4634032

Exact Mass

461.10600

PSA

146.97000

Logp

3.82910